Literature DB >> 9703155

Granulomatous skin infection caused by Scopulariopsis brevicaulis.

I Bruynzeel1, T M Starink.   

Abstract

A 14-year-old girl with a granulomatous infection of the cheek caused by Scopulariopsis brevicaulis is described. Treatment successively consisted of itraconazole and/or terbinafine for 19 months, after which clinical and mycologic cure seemed to be obtained. However, a relapse occurred 10 months later.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9703155     DOI： 10.1016/s0190-9622(98)70392-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  5 in total

1.  Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Emilia Mellado; Maria J Buitrago; Araceli Monzón; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

2.  In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Maria J Buitrago; Emilia Mellado; Guillermo Garcia-Effron; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  "Salt mummification" - atypical method of embalming a corpse.

Authors:  Łukasz Szleszkowski; Marcin Kadej; Rafał Ogórek; Agata Thannhäuser; Michał A Dobrowolski; Tomasz Jurek
Journal:  Int J Legal Med       Date:  2022-06-24       Impact factor: 2.791

4.  21-year retrospective study of the prevalence of Scopulariopsis brevicaulis in patients suspected of superficial mycoses.

Authors:  Anna B Macura; Magdalena Skóra
Journal:  Postepy Dermatol Alergol       Date:  2015-06-15       Impact factor: 1.837

5.  Onychomycosis caused by Scopulariopsis brevicaulis: report of two cases.

Authors:  Myung Hoon Lee; Sung Min Hwang; Moo Kyu Suh; Gyoung Yim Ha; Heesoo Kim; Jeong Young Park
Journal:  Ann Dermatol       Date:  2012-04-26       Impact factor: 1.444
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.